Estimaciones de analistas de Wall Street para Innate Pharma S.A. (IPHA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 4 |
| Mantener | 2 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 6 |
| Calificación media (1-5) | 0.67 |
Ratios de valoración
| Precio / Valor contable | -6.93 |
| EV / EBITDA | -2.50 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $56.2M | $32.6M | $79.9M | $69.0M | $69.8M | $12.1M | $57.7M | $51.9M | $12.6M | $2.8M |
| Coste de Ventas | $48.6M | $67.0M | $69.6M | $45.2M | $49.7M | $47.0M | $51.7M | $56.0M | $52.0M | 0 |
| Beneficio Bruto | $7.5M | -$34.4M | $10.3M | $23.8M | $20.1M | -$22.3M | $6.0M | $5.6M | $12.6M | $2.8M |
| I+D | $48.6M | $67.0M | $69.6M | $1.6M | $49.7M | $47.0M | $51.7M | $56.0M | $52.0M | $43.6M |
| Generales y Administrativos | $9.3M | $16.2M | $19.3M | $49.6M | $19.0M | $25.5M | $14.5M | $11.7M | $11.9M | $11.0M |
| Gastos Operativos | $48.6M | $72.6M | $74.7M | $50.9M | $19.0M | $25.5M | $63.4M | $18.3M | $64.2M | $56.2M |
| Beneficio Operativo | $7.6M | -$40.0M | $5.1M | -$27.1M | $1.1M | -$47.8M | -$57.4M | -$12.7M | -$51.6M | -$53.4M |
| EBITDA | $10.8M | -$35.6M | -$3.3M | -$20.9M | $13.3M | -$43.2M | -$12.3M | -$1.8M | -$46.9M | -$43.6M |
| Gastos por Intereses | $124000 | $113000 | $102000 | $229445 | $341000 | $312000 | $288000 | $640000 | $566000 | $440000 |
| Beneficio Antes de Impuestos | $12.9M | -$48.0M | $2.7M | -$20.8M | -$829000 | -$45.5M | -$58.0M | -$7.6M | -$49.5M | -$49.2M |
| Impuestos | $301000 | $368000 | -$333000 | $206000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $12.6M | -$48.4M | $3.0M | -$20.8M | -$64.0M | -$52.8M | -$58.1M | -$7.6M | -$49.5M | -$49.2M |
| BPA | $0.23 | $-0.89 | $0.05 | $-0.31 | $-0.01 | $-0.57 | $-0.73 | $-0.09 | $-0.61 | $-0.53 |
| BPA Diluido | $0.23 | $-0.89 | $0.05 | $-0.31 | $-0.01 | $-0.57 | $-0.73 | $-0.09 | $-0.61 | $-0.53 |
| Acciones en Circulación (Diluidas) | $53.9M | $54.4M | $58.8M | $66.9M | $78.9M | $79.5M | $79.6M | $84.1M | $81.1M | $89.4M |
Precio
| Precio | $2.01 |
| Capitalización | $189M |
| Bolsa | NASDAQ |
| País | FR |
Empresas relacionadas: APLT · CGEN · CRBP · CRDF · CYBN · ELTX · MIST
Explorar sector: Healthcare · Biotechnology
Más secciones de IPHA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones